GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atrion Corp (NAS:ATRI) » Definitions » Enterprise Value

Atrion (Atrion) Enterprise Value

: $702.1 Mil (As of Today)
View and export this data going back to 1972. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Atrion's Enterprise Value is $702.1 Mil. Atrion's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $23.0 Mil. Therefore, Atrion's EV-to-EBIT ratio for today is 30.53.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Atrion's Enterprise Value is $702.1 Mil. Atrion's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $38.1 Mil. Therefore, Atrion's EV-to-EBITDA ratio for today is 18.43.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Atrion's Enterprise Value is $702.1 Mil. Atrion's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $169.3 Mil. Therefore, Atrion's EV-to-Revenue ratio for today is 4.15.


Atrion Enterprise Value Historical Data

The historical data trend for Atrion's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,325.22 1,131.02 1,208.20 959.31 660.41

Atrion Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 959.31 1,087.55 994.03 727.18 660.41

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Atrion's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrion Enterprise Value Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Atrion's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Atrion's Enterprise Value falls into.



Atrion Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Atrion's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Atrion's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrion  (NAS:ATRI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Atrion's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=702.142/22.995
=30.53

Atrion's current Enterprise Value is $702.1 Mil.
Atrion's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Atrion's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=702.142/38.093
=18.43

Atrion's current Enterprise Value is $702.1 Mil.
Atrion's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $38.1 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Atrion's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=702.142/169.326
=4.15

Atrion's current Enterprise Value is $702.1 Mil.
Atrion's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $169.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrion Enterprise Value Related Terms

Thank you for viewing the detailed overview of Atrion's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrion (Atrion) Business Description

Traded in Other Exchanges
N/A
Address
One Allentown Parkway, Allen, TX, USA, 75002-4211
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Executives
Preston G Athey director ONE ALLENTOWN PKWY, ALLEN TX 75002
David A Battat officer: President & CEO 2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103
Jeannette Bankes director ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Morgan Hugh J Jr director
Ronald Nicholas Spaulding director ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Cindy Ferguson officer: Officer/ CFO ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffery Strickland officer: Vice President & CFO
Emile A Battat director, officer: Chairman ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Stupp John P Jr director STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124
Roger F Stebbing director
Ronald N Spaulding director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Richard O Jacobson director ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002
Maley John H P director 6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377
Margaret Maxwell Zagel director C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532

Atrion (Atrion) Headlines

From GuruFocus

Atrion Reports First Quarter 2023 Results

By sperokesalga sperokesalga 05-08-2023

Atrion Corporation Declares Quarterly Cash Dividend

By PurpleRose PurpleRose 07-14-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-29-2022

Atrion Corporation Increases Quarterly Cash Dividend by 10%

By PurpleRose PurpleRose 08-22-2022

Atrion Corporation Declares Quarterly Cash Dividend

By sperokesalga sperokesalga 02-27-2023

Atrion Corporation Announces CFO Succession Plan

By GlobeNewswire GlobeNewswire 08-25-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 07-08-2022

Atrion Corporation Increases Quarterly Cash Dividend by 10%

By GlobeNewswire GlobeNewswire 08-22-2022

Atrion Reports Third Quarter 2022 Results

By Value_Insider Value_Insider 11-08-2022

Atrion Corporation Declares Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 06-23-2022